Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dual Anti-platelet Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT04088513
What this trial is testing

Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST)

Who this might be right for
G6PD DeficiencyStroke
First Affiliated Hospital, Sun Yat-Sen University 440
Not applicableWithdrawnNCT06857045
What this trial is testing

Comparison Three vs Six Months of Dual Anti-platelet Therapy After Sirolimus-eluting Stent Implantation

Who this might be right for
Intracranial ArteriosclerosisIntracranial Artery StenosisDrug-Eluting Stents
Sino Medical Sciences Technology Inc.
Not applicableStudy completedNCT01175200
What this trial is testing

Double the Dose of Clopidogrel or Switch to Prasugrel to Antagonize Proton Pump Inhibitor Interaction.

Who this might be right for
Anti Platelet Effects
Ascopharm Groupe Novasco 82
Testing effectiveness (Phase 2)Study completedNCT05567562
What this trial is testing

Anti-Platelets in Chronic Obstructive Pulmonary Disease

Who this might be right for
COPDEmphysemaEmphysema or COPD
Brigham and Women's Hospital 15
Post-approval studies (Phase 4)WithdrawnNCT02144831
What this trial is testing

The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack

Who this might be right for
Transient Ischemic AttacksMinor Stroke
University of Alberta
Post-approval studies (Phase 4)UnknownNCT03908593
What this trial is testing

Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABG

Who this might be right for
Gastrointestinal Ulcer (Peptic) or ErosionAnti-Platelet TherapyCoronary Artery Bypass
Ruijin Hospital 232
Early research (Phase 1)Ended earlyNCT01561950
What this trial is testing

Efficacy of Activated Recombinant Human Factor VII in Healthy Volunteers Treated for Punch Biopsy Mediated Bleeding

Who this might be right for
HaemostasisHealthy
Novo Nordisk A/S 91
Large-scale testing (Phase 3)Looking for participantsNCT07512960
What this trial is testing

Duration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia After Distal Revascularization

Who this might be right for
CLTI Defined as Rutherford Category 4 or 5
Fondation Hôpital Saint-Joseph 614
Not applicableStudy completedNCT03848572
What this trial is testing

Repetitive Assessement of PRECISE-DAPT Score

Who this might be right for
Cardiovascular DiseasesInterventional Cardiology
University of Roma La Sapienza 500
Not applicableStudy completedNCT03601013
What this trial is testing

Demographical and Clinical Profile of Patients on Dual Antıplatelet Therapy and Mean Precise-DAPT and DAPT Scores in Turkey

Who this might be right for
Anti-platelet Therapy
Cardiovascular Academy Society, Turkey 963
Not applicableEnded earlyNCT02224235
What this trial is testing

COBRA SHIELD OCT Study

Who this might be right for
Stable Angina
CeloNova BioSciences, Inc. 8
Testing effectiveness (Phase 2)Study completedNCT03803007
What this trial is testing

Acute Ischemic Stroke Interventional Study

Who this might be right for
Acute Ischemic Stroke
Acticor Biotech 160
Not applicableUnknownNCT01233167
What this trial is testing

Effect of Different Anti-platelet Strategies on the Long-term Outcome After Sirolimus Drug-eluting Stent Implantation

Who this might be right for
Coronary Artery Disease
Sir Run Run Shaw Hospital 5,232
Not applicableStudy completedNCT05068414
What this trial is testing

Assessment of the Incidence of Hemorrhagic and Ischemic Events in Post-angioplasty in Anticoagulated Coronary Patients with Atrial Fibrillation

Who this might be right for
Atrial FibrillationAcute Coronary SyndromeThrombosis+1 more
Centre Hospitalier Universitaire de Nīmes 122
Post-approval studies (Phase 4)UnknownNCT03008083
What this trial is testing

Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation

Who this might be right for
Drug-Eluting StentsPercutaneous Coronary Intervention
Shanghai MicroPort Medical (Group) Co., Ltd. 2,446
Post-approval studies (Phase 4)Study completedNCT02330640
What this trial is testing

A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting

Who this might be right for
Antiplatelet Therapy of Coronary Artery Bypass
Chinese Academy of Medical Sciences, Fuwai Hospital 137
Not applicableStudy completedNCT01925794
What this trial is testing

COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT

Who this might be right for
Coronary Artery Disease
CeloNova BioSciences, Inc. 296
Large-scale testing (Phase 3)Study completedNCT00269880
What this trial is testing

A Study Comparing the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Combination With Two Different Heparin Regimens in Patients Undergoing Percutaneous Coronary Intervention.

Who this might be right for
Angioplasty, Transluminal, Percutaneous Coronary
Centocor, Inc. 2,792
Post-approval studies (Phase 4)UnknownNCT04090281
What this trial is testing

Implementing Precision Medicine Approaches to Guide Anti-platelet Selection

Who this might be right for
Acute Coronary Syndrome (ACS)STEMI - ST Elevation Myocardial Infarction (MI)NSTEMI - Non-ST Segment Elevation MI+1 more
University of Southern California 200
Post-approval studies (Phase 4)Ended earlyNCT01346865
What this trial is testing

Drug-Eluting Stenting Followed by Cilostazol tREAtment Reduces SErious Adverse Cardiac Events (DECREASE-PCI)

Who this might be right for
Coronary Artery Disease
Seung-Jung Park 402
Next Page